CCL5 and neoplasm: The primary tumor responded to PD1, OX40, and PD1+CTLA4 treatment with increased production of IFNg, and accompanying increases in the IFN-regulated chemokine IP-10 (CXCL10) (Figure 6Di) and the proinflammatory chemokine RANTES (not shown).